Cell and Gene Therapy Symposium: Streamlining Scale-Up and Scale-Out

Now available on-demand!
Cell and Gene Therapy Symposium: Streamlining Scale-Up and Scale-Out

Bio-Techne is hosting our next Cell and Gene Therapy Virtual Symposium.

At our last event, we discussed “The Challenges of Analyzing ATMPs” and our speakers shared solutions to overcome these challenges.

To create therapies that are accessible to all, it is key that manufacturing can be completed in a scalable and cost-effective manner. So, this time we shall be exploring the challenges and discussing possible solutions for streamlining the manufacturing process.

Join us and be part of the discussion on how we can streamline, scale-up and scale-out!
2:30 - 2:40 pm Welcome
2:40 - 2:55 pm David Hermansson
2:55 - 3:10 pm Katy Newton
3:10 - 3:25 pm Fernanda Masri
3:25 - 3:40 pm Cathelijine van den Berg
3:40 - 4:00 pm Roundtable
4:00 pm Closing the session



Jenny Stjernberg, Ph.D.
Commercial Development Manager - Cell & Gene Therapy, Europe at Bio-Techne

Symposium Host

David Hermanson.jpg

David Hermanson, PhD.
Senior Manager, R&D Applications, Cell and Gene Therapy, B-MoGen

“Scale-Up of Tcbuster Transposition: A Non-Viral Gene Editing Tool”

Katy Newton.jpg

Katy Newton, Ph.D.
Vice President Process Development at Achilles Therapeutics Limited

“Planning for Success - Considerations for the Design of Scalable Processes”


Fernanda Masri, Ph.D.
Solutions Manager for iPSCs – Sartorius Stedim Biotech
Co-Founder and Technical Director – Yres Consulting 

“Practical Considerations for Large Scale Realisation of ATMPs”

Cathelijne van den Berg.jpg

Cathelijne van den Berg, Ph.D.
Assistant Professor Nephrology at LUMC and Special Adviser for NECSTGEN.

“Roadmap for Clinical Grade Advanced Stem Cell Therapies for Patients with 
Kidney Disease”

If you have any questions about the event, please contact [email protected]